How COVID-19 will change the management of other respiratory viral infections
Intensive Care Med
.
2021 Oct;47(10):1148-1151.
doi: 10.1007/s00134-021-06491-2.
Epub 2021 Aug 11.
Authors
Yaseen M Arabi
1
2
3
,
Lennie P G Derde
4
5
,
Jean-François Timsit
6
7
Affiliations
1
Intensive Care Department, Ministry of the National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia. arabi@ngha.med.sa.
2
King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia. arabi@ngha.med.sa.
3
King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia. arabi@ngha.med.sa.
4
Intensive Care Centre, University Medical Center Utrecht, Utrecht, Netherlands.
5
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands.
6
AP-HP, Bichat Hospital, Medical and Infectious Diseases ICU (MI2), 75018, Paris, France.
7
University of Paris, IAME, INSERM, 75018, Paris, France.
PMID:
34379151
PMCID:
PMC8355267
DOI:
10.1007/s00134-021-06491-2
No abstract available
MeSH terms
COVID-19*
Humans
Respiratory Tract Infections* / therapy
SARS-CoV-2